HU196625B - Process for producing hepatitis b virus vaccine - Google Patents

Process for producing hepatitis b virus vaccine Download PDF

Info

Publication number
HU196625B
HU196625B HU833136A HU313683A HU196625B HU 196625 B HU196625 B HU 196625B HU 833136 A HU833136 A HU 833136A HU 313683 A HU313683 A HU 313683A HU 196625 B HU196625 B HU 196625B
Authority
HU
Hungary
Prior art keywords
fragment
hbsag
yeast
dna
regulatory region
Prior art date
Application number
HU833136A
Other languages
English (en)
Hungarian (hu)
Inventor
Marjolene Crabeel
Wilde Michel De
Nigel Harford
Theresa Cabezon
Original Assignee
Smith Kline Rit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline Rit filed Critical Smith Kline Rit
Publication of HU196625B publication Critical patent/HU196625B/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU833136A 1982-09-08 1983-09-08 Process for producing hepatitis b virus vaccine HU196625B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US41578982A 1982-09-08 1982-09-08

Publications (1)

Publication Number Publication Date
HU196625B true HU196625B (en) 1988-12-28

Family

ID=23647197

Family Applications (1)

Application Number Title Priority Date Filing Date
HU833136A HU196625B (en) 1982-09-08 1983-09-08 Process for producing hepatitis b virus vaccine

Country Status (22)

Country Link
EP (1) EP0106828B1 (OSRAM)
JP (5) JPS5971694A (OSRAM)
KR (1) KR840006014A (OSRAM)
AT (1) ATE91718T1 (OSRAM)
AU (4) AU584580B2 (OSRAM)
CA (1) CA1222707A (OSRAM)
CY (1) CY1932A (OSRAM)
DE (1) DE3382704T2 (OSRAM)
DK (1) DK406483A (OSRAM)
ES (4) ES8506350A1 (OSRAM)
FI (1) FI833205A7 (OSRAM)
GR (1) GR78982B (OSRAM)
HK (1) HK1004570A1 (OSRAM)
HU (1) HU196625B (OSRAM)
IE (1) IE60387B1 (OSRAM)
IL (1) IL69202A (OSRAM)
MA (1) MA19895A1 (OSRAM)
MY (1) MY102920A (OSRAM)
NO (1) NO833198L (OSRAM)
NZ (1) NZ204952A (OSRAM)
PT (1) PT77265B (OSRAM)
ZA (1) ZA836658B (OSRAM)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5936699A (ja) * 1982-08-20 1984-02-28 Chemo Sero Therapeut Res Inst シヤトルベクタ−
JPS5931799A (ja) * 1982-08-16 1984-02-20 Science & Tech Agency Ｂ型肝炎ウイルス遺伝子を組込んだ組換えプラスミド
WO1986001534A1 (fr) * 1984-09-04 1986-03-13 Takeda Chemical Industries, Ltd. Adn recombinant et son utilisation
WO1986007384A1 (fr) * 1985-06-03 1986-12-18 Takeda Chemical Industries, Ltd. Procede de preparation de l'antigene p31 de surface du virus de l'hepatite b
WO1986003411A1 (fr) * 1984-12-12 1986-06-19 Takeda Chemical Industries, Ltd. Procede de preparation d'une nouvelle proteine
US4683294A (en) * 1985-04-03 1987-07-28 Smith Kline Rit, S.A. Process for the extraction and purification of proteins from culture media producing them
DE3677851D1 (de) * 1985-08-05 1991-04-11 Merck & Co Inc Verfahren zur steigerung der produktion von rekombinantem protein in hefearten der gattung saccharomyces.
US4895800A (en) * 1985-11-26 1990-01-23 Phillips Petroleum Company Yeast production of hepatitis B surface antigen
ZA88488B (en) * 1987-01-30 1988-10-26 Smith Kline Rit Hepatitis b virus surface antigens and hybrid antigens containing them
ATE93891T1 (de) * 1987-03-09 1993-09-15 Merck & Co Inc Reinigung von rekombiniertem hepatitis-boberfl|chen-antigen.
NZ229260A (en) * 1988-06-03 1994-02-25 Merck & Co Inc Hepatitis b virus, expression cassette for pre-s domain, host cells and
US4962656A (en) * 1989-06-30 1990-10-16 The United States Of America As Represented By The United States Department Of Energy Control and monitoring method and system for electromagnetic forming process
LT3988B (en) 1992-02-17 1996-06-25 Fermentas Biotech Inst Recombinant plasmides pfs19, pfps2-48 and pjlfds1 codingsynthesis of human hepatite b of surfice virus antigenes, methods fof producing thereof
TW340132B (en) * 1994-10-20 1998-09-11 Ibm Structure for use as an electrical interconnection means and process for preparing the same
JP4028850B2 (ja) * 2004-02-04 2007-12-26 株式会社名機製作所 ディスク基板の成形用金型

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI86437C (fi) * 1978-12-22 1992-08-25 Biogen Inc Foerfarande foer framstaellning av polypeptider med de antigena egenskaperna hos ett hepatitis b- virusantigen.
NZ199722A (en) * 1981-02-25 1985-12-13 Genentech Inc Dna transfer vector for expression of exogenous polypeptide in yeast;transformed yeast strain
GR76274B (OSRAM) * 1981-08-04 1984-08-04 Univ California
NZ201705A (en) * 1981-08-31 1986-03-14 Genentech Inc Recombinant dna method for production of hepatitis b surface antigen in yeast
GB2125047B (en) * 1982-08-09 1986-02-19 Ciba Geigy Ag Yeast hybrid vectors and their use for the production of polypeptides

Also Published As

Publication number Publication date
JPH02116A (ja) 1990-01-05
MA19895A1 (fr) 1984-04-01
ES8600938A1 (es) 1985-10-16
DK406483A (da) 1984-03-09
JPS5971694A (ja) 1984-04-23
PT77265B (en) 1986-02-04
GR78982B (OSRAM) 1984-10-02
JPH08317796A (ja) 1996-12-03
FI833205L (fi) 1984-03-09
FI833205A7 (fi) 1984-03-09
ES8600939A1 (es) 1985-10-16
JPH02464A (ja) 1990-01-05
FI833205A0 (fi) 1983-09-07
KR840006014A (ko) 1984-11-21
ES8602120A1 (es) 1985-11-01
EP0106828A2 (fr) 1984-04-25
AU9001491A (en) 1992-02-27
ATE91718T1 (de) 1993-08-15
ES532731A0 (es) 1985-11-01
ES532730A0 (es) 1985-10-16
CY1932A (en) 1983-09-06
ZA836658B (en) 1984-06-27
ES525439A0 (es) 1985-07-01
EP0106828B1 (fr) 1993-07-21
AU3131889A (en) 1989-07-20
JP2522825B2 (ja) 1996-08-07
DE3382704T2 (de) 1994-02-10
NZ204952A (en) 1986-05-09
DE3382704D1 (de) 1993-08-26
CA1222707A (en) 1987-06-09
ES8506350A1 (es) 1985-07-01
HK1004570A1 (en) 1998-11-27
ES532732A0 (es) 1985-10-16
AU1569288A (en) 1988-07-28
AU1675083A (en) 1984-03-15
IE832099L (en) 1984-03-08
EP0106828A3 (en) 1985-11-21
IE60387B1 (en) 1994-07-13
NO833198L (no) 1984-03-09
IL69202A (en) 1991-08-16
DK406483D0 (da) 1983-09-07
JPH02231084A (ja) 1990-09-13
MY102920A (en) 1993-03-31
PT77265A (en) 1983-09-01
JP2702899B2 (ja) 1998-01-26
AU584580B2 (en) 1989-06-01

Similar Documents

Publication Publication Date Title
EP0522030B1 (en) Hepatitis b vaccine
US4722840A (en) Hybrid particle immunogens
US5990085A (en) Inhibin-HBc fusion protein
US20040054139A1 (en) Modification of hepatitis b core antigen
HUT50876A (en) Process for producing hepatitis b virus surface antigenes and hybrid antigenes containing same, as well as pharmaceutical compositions comprising same
US20030175296A1 (en) Chimaeric hepadnavirus core antigen proteins
JPS6362198B2 (OSRAM)
HU196625B (en) Process for producing hepatitis b virus vaccine
US5098704A (en) Hepatitis surface antigen particle vaccine
HK1004570B (en) Recombinant dna molecules encoding for hepatitis b surface antigen, their preparation and derived vaccines
US4820642A (en) Amplified expression vector
CN119735707B (zh) 一种猴痘病毒多抗原单价疫苗及其应用
JP3242640B2 (ja) 高免疫能を有するｂ型肝炎ウイルス組換え表面抗原およびｂ型肝炎ウイルスワクチン組成物
US5639637A (en) Hepatitis B vaccine
KR100587944B1 (ko) 보강제 및 ＨＢＶ 백신 성분인 Ｂ형 간염 바이러스의ｐｒｅ Ｓ단백질
HUP0003511A2 (hu) Hepatitisz-B-vírus polipeptidek
US6096879A (en) Nucleotide sequence comprising the genome of hepatitis B virus, nucleotide sequence coding the surface antigen of the hepatitis B virus, vectors containing the nucleotide sequences, process for the preparation thereof, and antigen obtained thereby
US5989865A (en) Hepatitis B vaccine
AU642729C (en) Hepatitis B vaccine
US6416996B1 (en) Nucleotide sequence comprising the genome of hepatitis b virus, nucleotide sequence coding the surface antigen of the hepatitis b virus, vectors containing the nucleotide sequences, process for the preparation thereof, and antigen obtained thereby
JPS6274295A (ja) ハイブリツド粒状免疫原
JPS62181785A (ja) 融合蛋白質の製造方法
CA2244881A1 (en) Amplification of response from expressed recombinant protein

Legal Events

Date Code Title Description
HU90 Patent valid on 900628
HMM4 Cancellation of final prot. due to non-payment of fee